Discover 2,367 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Plainfield offers many clinical trial opportunities with focuses on various conditions, including ADHD, prurigo nodularis, autoimmune diseases like lupus, and cardiovascular conditions. The city's leading institutions are actively recruiting both healthy volunteers interested in paid research options, as well as those with specific health conditions for studies that could lead to groundbreaking discoveries and improved treatments.
Filter
2
Filter results
Results: 2,367
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
for
Ischemic Stroke, Intracerebral Hemorrhage,
Location: Chicago IL, Indianapolis IN, Cincinnati OH,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT04916210
Recruiting
Aspirin and Preeclampsia
for
Preeclampsia Postpartum
Location: Chicago IL
Sponsor: University of Chicago
Sex: Female
Age: 18 - 45
Code: NCT04479072
Recruiting
Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding
for
Acute Gastrointestinal Bleeding
Location: Chicago IL, Toronto, Piscataway NJ, New York NY,
Sponsor: Medtronic - MITG
Sex: All
Age: 22+
Code: NCT06188585
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Chicago IL, Niles IL, Janesville WI, Dayton OH,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT05920356
Phase3, Recruiting
Mechanical Alignment vs Kalipered Kinematic Alignment Total Knee Arthroplasty
for
Knee Osteoarthritis, Knee Arthropathy
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 21 - 70+
Code: NCT06617871
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
for
Solid Tumor
Location: Chicago IL, Iowa City IA, St Louis MO, Detroit MI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT04939610
Phase1, Phase2, Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Chicago IL, Milwaukee WI, Atlanta GA, Chapel Hill NC,
Sponsor: Ichnos Sciences SA
Sex: All
Age: 18+
Code: NCT05862012
Phase1, Recruiting
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
Location: Chicago IL, Indianapolis IN, Washington DC, New York NY,
Sponsor: Recordati Rare Diseases
Sex: All
Age: 0+
Code: NCT05040178
Recruiting
Islet Transplantation in Patients With "Brittle" Type I Diabetes
for
Diabetes Mellitus, Type 1
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18 - 70
Code: NCT01630850
Recruiting
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
for
Ovarian Cancer
Location: Chicago IL
Sponsor: Canadian Cancer Trials Group
Sex: Female
Age: 18+
Code: NCT04918186
Phase2, Recruiting
The Pediatric Anesthesia Quality Improvement Project
for
Surgery, Anesthesia, Children
Location: Chicago IL, Iowa City IA, ST Louis MO, Ann Arbor MI,
Sponsor: The Society for Pediatric Anesthesia
Sex: All
Age: 0 - 21
Code: NCT00674388
Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Chicago IL, Detroit MI, Columbus OH, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase1, Phase2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Chicago IL, Madison WI, Ann Arbor MI, Rochester MN,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase3, Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
for
Relapsed Hematologic Malignancy,
Location: Chicago IL, Rochester MN, Cleveland OH, Omaha NE,
Sponsor: Curis, Inc.
Sex: All
Age: 18+
Code: NCT03328078
Phase1, Phase2, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)